These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6142310)

  • 1. Lymphoma in organ transplant recipients.
    Lancet; 1984 Mar; 1(8377):601-3. PubMed ID: 6142310
    [No Abstract]   [Full Text] [Related]  

  • 2. Virus-induced lymphomas in transplant patients under immunosuppressive therapy.
    Touraine JL; Deteix P; el Yafi M; Traeger J; Dubernard JM; LeFrancois N; Lenoir G; de Thé G
    Transplant Proc; 1987 Oct; 19(5):4087-8. PubMed ID: 2823437
    [No Abstract]   [Full Text] [Related]  

  • 3. EBV-induced post-transplant lymphoproliferative disorder (PTLD).
    Birkeland SA; Hamilton-Dutoit S; Sandvej K; Andersen HM; Bendtzen K; Møller B; Jørgensen KA
    Transplant Proc; 1995 Dec; 27(6):3467-72. PubMed ID: 8540055
    [No Abstract]   [Full Text] [Related]  

  • 4. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy.
    Starzl TE; Nalesnik MA; Porter KA; Ho M; Iwatsuki S; Griffith BP; Rosenthal JT; Hakala TR; Shaw BW; Hardesty RL
    Lancet; 1984 Mar; 1(8377):583-7. PubMed ID: 6142304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphoproliferative disease in organ transplant recipients.
    Nalesnik MA
    Springer Semin Immunopathol; 1991; 13(2):199-216. PubMed ID: 1664986
    [No Abstract]   [Full Text] [Related]  

  • 6. [Viral infections in solid organ transplant recipients].
    Moreno MA
    Enferm Infecc Microbiol Clin; 1997 May; 15 Suppl 2():22-33. PubMed ID: 9312296
    [No Abstract]   [Full Text] [Related]  

  • 7. Posttransplantation lymphoproliferative disorder in liver recipients: characteristics, management, and outcome.
    Ben-Ari Z; Amlot P; Lachmanan SR; Tur-Kaspa R; Rolles K; Burroughs AK
    Liver Transpl Surg; 1999 May; 5(3):184-91. PubMed ID: 10226108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complications of Immunosuppressive Therapy in Solid Organ Transplantation.
    Katabathina V; Menias CO; Pickhardt P; Lubner M; Prasad SR
    Radiol Clin North Am; 2016 Mar; 54(2):303-19. PubMed ID: 26896226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonality of lymphoproliferative lesions in cardiac-transplant recipients. Clonal analysis based on immunoglobulin-gene rearrangements.
    Cleary ML; Warnke R; Sklar J
    N Engl J Med; 1984 Feb; 310(8):477-82. PubMed ID: 6363929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The molecular biology of lymphotropic herpesviruses.
    Sugden B; Kintner CR; Mark W
    Adv Cancer Res; 1979; 30():239-78. PubMed ID: 228536
    [No Abstract]   [Full Text] [Related]  

  • 11. Post-transplant lymphoproliferative disorders: improved outcome after clinico-pathologically tailored treatment.
    Muti G; Cantoni S; Oreste P; Klersy C; Gini G; Rossi V; D'Avanzo G; Comoli P; Baldanti F; Montillo M; Nosari A; Morra E;
    Haematologica; 2002 Jan; 87(1):67-77. PubMed ID: 11801467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neoplasia in lung transplants].
    Blanco Aparicio M; Montero Martínez C
    Arch Bronconeumol; 2009 Aug; 45(8):363-5. PubMed ID: 19592149
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunosuppressed solid organ transplant recipient.
    Stine JG; Shah N; Argo C
    Gastroenterology; 2014 Feb; 146(2):345,590. PubMed ID: 24342810
    [No Abstract]   [Full Text] [Related]  

  • 14. Transplant immunosuppression-related malignant lymphomas.
    Swinnen LJ
    Cancer Treat Res; 1993; 66():95-110. PubMed ID: 8102866
    [No Abstract]   [Full Text] [Related]  

  • 15. [Post-transplantation lymphomas and Epstein-Barr virus].
    Caillard S; Heibel F; Benaicha M; Moulin B
    Nephrologie; 1998; 19(8):481-8. PubMed ID: 9894641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute renal allograft rejection in patients with Epstein-Barr virus associated post-transplant lymphoproliferative disorder.
    Purighalla R; Shapiro R; Jordan ML; Scantlebury VP; Gritsch HA; Vivas C; Randhawa PS
    Clin Transplant; 1997 Dec; 11(6):574-6. PubMed ID: 9408687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus-associated lymphoproliferative disorder after autologous bone marrow transplantation: report of two cases.
    Hauke RJ; Greiner TC; Smir BN; Vose JM; Tarantolo SR; Bashir RM; Bierman PJ
    Bone Marrow Transplant; 1998 Jun; 21(12):1271-4. PubMed ID: 9674863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lymphoproliferative disease and cancer in the transplant patient].
    Herreros J; Flórez S; Echevarría JR; Fernández AL; Pardo Mindán FJ
    Rev Esp Cardiol; 1995; 48 Suppl 7():129-34. PubMed ID: 8775827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral infections in renal transplant recipients: an evolutionary problem.
    Charpentier B
    Adv Nephrol Necker Hosp; 1986; 15():353-78. PubMed ID: 3006452
    [No Abstract]   [Full Text] [Related]  

  • 20. Overview of posttransplant B-cell lymphoproliferative disorders.
    Swinnen LJ
    Semin Oncol; 1999 Oct; 26(5 Suppl 14):21-5. PubMed ID: 10561014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.